Bradford S Goodwin's Net Worth
$1.06 Million
Who is Bradford S Goodwin?
Bradford S Goodwin has an estimated net worth of $1.06 Million. This is based on reported shares across multiple companies, which include COTHERIX INC, FACET BIOTECH CORP, NeurogesX Inc, RIGEL PHARMACEUTICALS INC, NOVACEA INC, and PDL BIOPHARMA, INC..
SEC CIK
Bradford S Goodwin's CIK is 0001293633
Past Insider Trading and Trends
2007 was Bradford S Goodwin's most active year for acquiring shares with 17 total transactions. Bradford S Goodwin's most active month to acquire stocks was the month of April. 2007 was Bradford S Goodwin's most active year for disposing of shares, totalling 4 transactions. Bradford S Goodwin's most active month to dispose stocks was the month of December. 2011 saw Bradford S Goodwin paying a total of $103,200.00 for 115,000 shares, this is the most they've acquired in one year. In 2010 Bradford S Goodwin cashed out on 40,001 shares for a total of $1,080,027.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
COTHERIX INC No price found
InvestorBradford S Goodwin used to own units in Common Stock but no longer holds any shares there.disposed a total of 39,390 shares of COTHERIX INC equalling to $531,765.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -39.39K |
$13.50 | -$531,765.00 |
0
|
Jan 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FACET BIOTECH CORP No price found
InvestorBradford S Goodwin used to own units in Common Stock but no longer holds any shares there.acquired a total of 13,334 shares in FACET BIOTECH CORP, Bradford also disposed a total of 13,334 shares of FACET BIOTECH CORP equalling to $360,018.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.33K |
$27.00 | -$90,018.00 |
0
|
Apr 21
| |||
Form 4
| -75.00% | -10.00K |
$27.00 | -$270,000.00 | 3.33K |
Apr 20
| |||
Form 4
| +33.34% | 3.33K |
—
|
—
| 13.33K |
May 26
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Jan 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NeurogesX Inc No price found
InvestorBradford S Goodwin owns 75,000 units of Common Stock. In the year 2009 Bradford S Goodwin filed a total of 12 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
| +26.67% | 20K |
$1.01 | $20,200.00 | 95K |
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 25
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 26
| |||
Form 4
| +400.00% | 60K |
$1.65 | $99,000.00 | 75K |
Jul 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
| +50.00% | 5K |
$6.03 | $30,155.00 | 15K |
Aug 10
| |||
Form 4
|
∞
| 10K |
$7.27 | $72,734.40 | 10K |
Jun 7 - Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RIGEL PHARMACEUTICALS INC (RIGL) Snapshot price: $13.32
InvestorBradford S Goodwin owns 35,000 units of Common Stock which is worth $466,200.00. From 2007 to 2019 Bradford S Goodwin acquired a total of 35,000 shares in RIGEL PHARMACEUTICALS INC at a cost of $99,276.15.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +250.00% | 25K |
—
|
—
| 35K |
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
∞
| 10K |
$9.93 | $99,276.15 | 10K |
Aug 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NOVACEA INC No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.95% | 16.33K |
—
|
—
| 152.89K |
May 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||